ARTICLE | Clinical News
Staphylokinase: Phase III started
February 14, 2011 8:00 AM UTC
Bharat began an open-label, Indian Phase III trial to compare a 30 mL double-bolus of staphylokinase vs. IV streptokinase in about 120 AMI patients. Bharat has an exclusive license from ThromboGenics ...